Scotland’s Thriving Life Sciences Sector Defies PredictionsSteve Jarvis2024-03-21T15:55:33+00:00March 21st, 2024|BioCity Glasgow, Edinburgh Technopole, Investment, News|
Pioneer Group Leads $2.34m Investment in Neobe Therapeutics’ Cancer Therapy InnovationSteve Jarvis2024-02-29T15:29:10+00:00February 29th, 2024|Investment, News|
BioCity Glasgow: BioAscent Invests in New State-of-the-Art Protein Production FacilitySteve Jarvis2024-02-23T15:02:55+00:00February 23rd, 2024|BioCity Glasgow, Investment, News|
IsomAb Closes £7.5m Financing to Drive New Diabetic TreatmentSteve Jarvis2024-03-01T16:00:27+00:00February 21st, 2024|BioCity Nottingham, Investment, News|
MIP Discovery Raises £7m to Advance CommercialisationSteve Jarvis2024-02-21T15:26:40+00:00February 21st, 2024|Colworth Park, Investment, News|
Ireland Accelerator Programme Winners NeuroBell Secure £1.8m Funding RoundSteve Jarvis2024-01-31T12:30:00+00:00January 31st, 2024|Accelerator, News|
Pioneer Group and CPI Collaborate on ‘Golden Ticket’ Programme for Planetary Health InnovationsSteve Jarvis2024-02-23T12:11:13+00:00January 30th, 2024|Accelerator, News, Wilton Centre|
Pioneer Group and Innovate UK Join Forces to Accelerate the Development of Life Sciences Companies Steve Jarvis2023-12-11T09:47:26+00:00December 11th, 2023|Investment, News|
Pioneer Life Sciences Fund Invests in First of its Kind At-Home Fertility Care Company Béa Fertility Steve Jarvis2023-11-22T15:38:34+00:00November 22nd, 2023|Investment, News|
Operational Excellence Will Be Key in a Maturing Life Sciences MarketSteve Jarvis2023-11-21T17:10:40+00:00November 21st, 2023|Article, Investment, News|
